TRT Injections vs Gels vs Pellets: What Urologists Rank by Safety and Long-Term Results

A 62-year-old man walks into a urologist's office with fatigue, low libido, and weight gain. His testosterone is 240 ng/dL—well below the 300 ng/dL threshold that signals low testosterone. The doctor outlines three delivery methods: intramuscular injections, transdermal gels, and subcutaneous pellets. Each works. Each carries tradeoffs. And the choice he makes will shape his treatment experience—and his wallet—for years.

Testosterone replacement therapy (TRT) is no longer niche medicine. Testosterone levels naturally drop 1% per year starting in men's late 30s, and conditions like obesity, Type 2 diabetes, and sleep apnea accelerate that decline. When lifestyle changes don't reverse the slide, patients face a real decision: which delivery method actually delivers the best long-term outcomes, fewest complications, and best value?

Why Delivery Method Matters More Than You Think

The form of testosterone you choose isn't cosmetic. It determines how steadily your hormone levels stay within range, how often you visit the clinic, whether you risk accidental exposure to family members, and how your body metabolizes the hormone over months and years.

Injections create a boom-and-bust cycle. You receive a dose—typically 50 to 100 mg of testosterone cypionate or enanthate weekly, or 200 to 250 mg every two weeks—and testosterone spikes within 24 to 48 hours. Then it declines gradually until your next injection. Some men feel energized and sexually responsive in the first week post-injection; others experience mood swings, fatigue, or irritability as levels drop before the next dose. This roller coaster isn't just uncomfortable—it can affect mood stability and sexual function unpredictably.

Gels and creams absorb through the skin and maintain steadier levels throughout the day. You apply them once daily, and hormone concentration stays relatively flat. That consistency appeals to men who've experienced the emotional volatility of injections. But gels demand discipline: you must apply them at the same time each day, avoid showering for several hours, and keep treated skin covered to prevent transfer to partners or children.

Pellets bypass both variability and daily application. A urologist implants small cylinders—each containing crystallized testosterone—under the skin of the hip or buttock. Over three to six months, the pellets dissolve and release testosterone steadily. You forget about treatment entirely until the next insertion. But pellets are irreversible once placed, carry infection risk at the insertion site, and cost significantly more upfront.

Injections: The Gold Standard for Reliability—and Mood Swings

Intramuscular testosterone injections remain the most prescribed form of TRT in urology practices. They're inexpensive, reliable, and well-understood across decades of clinical use. A vial costs $30 to $60 per month. Insurance covers them routinely. You inject once or twice weekly, and testosterone levels respond predictably.

The catch: that predictability is a curve, not a plateau. Injections create a sawtooth pattern of hormone levels. Testosterone peaks 24 to 48 hours after injection, then declines steadily. Some men adapt well. Others report energy crashes mid-cycle, mood irritability, or erectile dysfunction that worsens as levels drop. One urologist's patient described it as "feeling great for three days, then flat for four."

This volatility matters clinically. Men on injections show higher rates of hematocrit elevation—a thickening of blood that increases stroke and clotting risk—compared to steady-delivery methods. They also experience more acne and, in some cases, increased aggression or irritability during the trough phase. Long-term studies show that while injections are safe when monitored, the hormonal swings can destabilize mood in men with underlying depression or anxiety.

Pain at the injection site is common but manageable. Rotating injection sites—alternating between glutes and thighs—reduces abscess risk and tissue damage. Many patients self-inject at home after training, which adds convenience but requires needle-safety discipline.

The fertility angle is critical. Testosterone therapy suppresses sperm production by reducing FSH and LH signaling to the testes. Men on injections who later want biological children face a 6- to 12-month recovery period after stopping, with no guarantee of full fertility return. Younger men considering TRT should discuss this upfront.

Gels and Creams: Steady Delivery, Daily Friction

Transdermal gels—brands like AndroGel and Testim—deliver testosterone through the skin at a constant rate. Men apply 50 to 100 mg daily, typically in the morning. Absorption is reliable; blood levels remain stable throughout the day. Gels avoid the mood swings and hematocrit spikes associated with injections, making them attractive for men sensitive to hormonal fluctuations.

The trade-off is adherence. You must apply gel every single day, at roughly the same time, to maintain therapeutic levels. Miss two or three days, and your testosterone drops noticeably. This daily ritual works for some men but frustrates others. Patients describe it as a medication burden that injections—given weekly or biweekly—don't impose.

Skin irritation is common. Redness, itching, or dermatitis develops in 10 to 15% of users. Switching brands or applying to different body sites sometimes helps, but some men abandon gels for this reason alone.

Transfer risk is real and underestimated. Testosterone gel transfers to skin contact with partners and children. If a woman or child absorbs significant testosterone, virilization can occur—voice deepening, clitoral enlargement, or accelerated puberty in children. The label says to cover treated skin and avoid contact for at least six hours, but real-world compliance is poor. Families living in close quarters—shared beds, young children climbing on parents—face genuine risk.

Cost varies. Generic testosterone gels run $40 to $80 monthly with insurance; brand names cost $150 to $300. Out-of-pocket, gels are more expensive than injections but cheaper than pellets.

Pellets: Convenience at a Premium Price

Subcutaneous testosterone pellets dissolve slowly under the skin, releasing hormone for three to six months. A urologist makes a small incision, inserts 4 to 10 pellets (each 75 mg), and closes the site. You then forget about testosterone until the next insertion.

This "set it and forget it" appeal drives pellet adoption. Men appreciate the absence of daily gels, weekly injections, or mood swings. Pellets maintain steady hormone levels comparable to gels, avoiding the hematocrit and mood volatility of injections.

But pellets carry distinct risks. Extrusion—where a pellet works its way out of the skin—occurs in 5 to 10% of insertions. Infection at the incision site, though rare, requires antibiotics and occasionally surgical removal. Some men report persistent bruising or tenderness at the insertion site for weeks.

Dosing is also less flexible. Once inserted, pellets release testosterone at a fixed rate. If side effects develop or levels run too high, you can't adjust the dose until the pellets dissolve. Removal is possible but requires minor surgery. Injections and gels allow immediate dose adjustment; pellets don't.

Cost is the biggest barrier. Pellet insertion runs $800 to $2,000 per procedure, with insertions needed every three to six months. Over a year, that's $1,600 to $8,000—five to ten times the cost of injections or gels. Insurance coverage varies; many plans classify pellets as experimental and deny reimbursement.

What Urologists Actually Rank First

When urologists assess long-term safety and outcomes, consistency of hormone delivery emerges as the primary factor. Steady-state methods (gels and pellets) produce fewer cardiovascular complications, better mood stability, and lower hematocrit elevation than injections.

But "best" depends on the patient. A man with a stable routine and no skin sensitivity thrives on gels. A man who travels frequently or dislikes daily medication prefers injections or pellets. A man with a partner and young children should avoid gels due to transfer risk.

The financial reality: injections are cheapest, gels mid-range, pellets most expensive. Yet pellets justify cost for some men through convenience and compliance. Gels justify cost through steady delivery. Injections justify cost through price alone—they're the budget option, not the best option.

Monitoring is non-negotiable across all methods. Testosterone levels should be checked 4 to 6 weeks after starting, then annually. Hematocrit, prostate-specific antigen (PSA), and lipid panels require regular review. Men who skip follow-up appointments face real risk: undetected hematocrit elevation, prostate growth, or testosterone levels that drift dangerously high.